US Patent 12059473 Humanized anti-prostate -specific membrane antigen (PSMA) antibody drug conjugates
Patent 12059473 was granted and assigned to AMBRX INC on August, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2024
Golden AI
Edits made to:
Infobox (+17 properties)
Article (+319 characters)
US Patent 12059473 Humanized anti-prostate -specific membrane antigen (PSMA) antibody drug conjugates
Article
Patent abstract
The invention relates to prostate specific membrane antigen humanized antibodies (anti-PSMA) and anti-PSMA antibody drug conjugates. The invention also relates to methods and compositions for using anti-PSMA antibody drug conjugates in inhibiting, preventing or treating PSMA related diseases or cancers.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Feng Tian0
Jianing Wang0
Jinming Xia0
Shivarupam Bhowmik0
William Brady0
Date of Patent
August 13, 2024
0Patent Application Number
170428380
Date Filed
March 29, 2019
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 12059473 Humanized anti-prostate -specific membrane antigen (PSMA) antibody drug conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
